Volume 45, Issue 2 pp. 174-178
Article
Full Access

Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, Western China

Rong-Rong Wu

Rong-Rong Wu

Department of Biochemistry, Nagoya City University Medical School, Nagoya, Japan

Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Akira Hata

Akira Hata

Institute of Medical Science, St. Marianne Medical University, Kawasaki, Japan

Search for more papers by this author
Makoto Sasaki

Makoto Sasaki

Section of Hepatobiliary Diseases, Division of Gastroenterology, Hepatology and Nutrition, Unversity of Florida, Gainesville, Florida

Search for more papers by this author
Masashi Mizokami M. D.

Corresponding Author

Masashi Mizokami M. D.

Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Second Department of Internal Medicine, Nagoya City University Medical School, Kawasumi, Mizuho, Nagoya 467, Japan===Search for more papers by this author
Tomoyoshi Ohno

Tomoyoshi Ohno

Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Ken-ichi Ohba

Ken-ichi Ohba

Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Xiao-Shan Wu

Xiao-Shan Wu

Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Shiro Iino

Shiro Iino

Institute of Medical Science, St. Marianne Medical University, Kawasaki, Japan

Search for more papers by this author
Johnson Y. N. Lau

Johnson Y. N. Lau

Section of Hepatobiliary Diseases, Division of Gastroenterology, Hepatology and Nutrition, Unversity of Florida, Gainesville, Florida

Search for more papers by this author
Zhi-Xun Fang

Zhi-Xun Fang

Department of Medicine, Zhong Fu Hospital, Nanjin China

Search for more papers by this author
First published: February 1995
Citations: 14

Abstract

The seroprevalence of hepatitis C virus (HCV) infection in Lanzhou, Western China was studied. HCV genotypes in 20 patients with HCV infection was determined by genotype-specific primer for polymerase chain reaction (PCR) based on HCV core region and compared with the genotype assigned by sequence comparison and molecular evolutionary analysis based on the same region. Antibody to HCV (anti-HCV) was present in 2.5% of volunteer blood donors and in 35.0% of paid blood donors (P < 0.01). HCV infection is uncommon in patients with liver disease who attended liver clinics in this locality; 4.0% with acute hepatitis and 4.0% with chronic hepatitis, 10.0% with liver cirrhosis, and none with hepatocellular carcinoma were seropositive for anti-HCV. Genotype 1b and 2a were both found to be prevalent. Together, they accounted for 19 of 20 (95%) patients with HCV infection. Sequencing of the HCV core region from two patients showed that the assignment of HCV genotype by genotype-specific primers for PCR matched well with the genotyping results based on sequence comparison and molecular evolutionary analysis. These data showed that HCV is present in Western China, HCV infection is more common in paid blood donors, and HCV genotypes 1b and 2a are both prevalent in Western China. © 1995 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.